Skip to main content

Portside Wealth Group, LLC

SEC CIK
0001978608
Latest filing
Jul 14, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Portside Wealth Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
5,258
Value
$2.61M
% of portfolio
0.3%
Quarters held
13
Since Q2 2023
Holdings of VRTX by Portside Wealth Group, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20265,258$2.61M0.3%+434+9.0%AddedHolders
Q1 20264,824$2.15M0.3%+510+11.8%AddedHolders
Q4 20254,314$1.96M0.3%+571+15.3%AddedHolders
Q3 20253,743$1.47M0.2%+545+17.0%AddedHolders
Q2 20253,198$1.42M0.2%+253+8.6%AddedHolders
Q1 20252,945$1.43M0.2%+679+30.0%AddedHolders
Q4 20242,266$912.5K0.2%+261+13.0%AddedHolders
Q3 20242,005$932.5K0.2%+193+10.7%AddedHolders
Q2 20241,812$849.3K0.2%+30+1.7%AddedHolders
Q1 20241,782$744.9K0.1%+126+7.6%AddedHolders
Q4 20231,656$673.8K0.1%+144+9.5%AddedHolders
Q3 20231,512$522.0K0.1%+226+17.6%AddedHolders
Q2 20231,286$452.6K0.1%–No prior filingHolders